Flinders uni raises $50m from USA institutions to develop world’s first flu vaccination
Australian researchers just released the world’s first AI-developed vaccine and it could prevent another horror flu season.
Researchers at Flinders University have developed a new vaccine believed to be the first in the world to be designed by an AI program called SAM (Search Algorithm for Ligands).
Funded by the US National Institute of Allergy and Infectious Diseases to the tune of $50m, the vaccine is currently being rolled out for 12-month trials in the US.
The rammifications could be huge, with the technology expected to be able to create better vaccines years ahead of humans and at a fraction of the cost.
Posted on August 11, 2019
Research Director of Australian biotechnology company Vaxine and Flinders University Professor Nikolai Petrovsky led this development with the help of USA NIH funding to the tune of $50m, after being rejected for funding by Australian institutions.
This was exceptional as Australia has a great record at publishing basic medical science and has a poor track record of developing new drugs or treatments. “
“The US system values ambitious, innovative and futuristic research whereas Australian funding bodies are highly conservative and only fund me-too incremental research where the outcome is largely already known,”
Leave a Reply
Latest Blogs
